Cinven Pays $915M For Clinical Research Co. Medpace
Under the terms of the transaction, Cinven will also hand over certain cash inflows relating to CCMP's period of ownership, the firm said. The transaction is subject to regulatory approval before completion.
Medpace helps plan and oversee clinical trials for the research and development departments of pharmaceutical, biotech...
To view the full article, register now.